Home Featured Page 230

Featured

Latest

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone...

Awakn Establishes Separate Preclinical and Clinical Expert Advisory Boards to Optimize...

Q & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of...

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved...

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary...

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative...

Delix Therapeutics Expands Executive Leadership Team

Horizons ETFs Rebalances World’s First Psychedelics ETF

MYND Life Sciences Provides Corporate Update

1...229230231...296 Page 230 of 296

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone...

Awakn Establishes Separate Preclinical and Clinical Expert Advisory Boards to Optimize...

Q & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of...

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved...

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary...

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative...

Delix Therapeutics Expands Executive Leadership Team

Horizons ETFs Rebalances World’s First Psychedelics ETF

MYND Life Sciences Provides Corporate Update

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY